Cargando…
Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study
BACKGROUND: Chronic liver disease (CLD) related thrombocytopenia increases the risk of bleeding and poor prognosis. Many liver disease patients require invasive procedures or surgeries, such as liver biopsy or endoscopic variceal ligation, and most of them have lower platelet counts, which could agg...
Autores principales: | Ding, Jing-Nuo, Feng, Ting-Ting, Sun, Wei, Cai, Xin-Yi, Zhang, Yun, Zhao, Wei-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727570/ https://www.ncbi.nlm.nih.gov/pubmed/36504518 http://dx.doi.org/10.4240/wjgs.v14.i11.1260 |
Ejemplares similares
-
Correlation between thrombopoietin and inflammatory factors, platelet indices, and thrombosis in patients with sepsis: A retrospective study
por: Xu, Wan-Hua, et al.
Publicado: (2022) -
Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists
por: Nilles, Kathy M., et al.
Publicado: (2019) -
Recombinant human thrombopoietin therapy for primary immune thrombocytopenia in pregnancy: a retrospective comparative cohort study
por: Lin, Jing, et al.
Publicado: (2023) -
Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures
por: Katsube, Takayuki, et al.
Publicado: (2019) -
Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China
por: Yan, Yun-Wei, et al.
Publicado: (2023)